| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:mdxg | nasdaq:mdxg Shareholders | 13F-HR | 0000950123-22-006331 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Nuveen Asset Management, LLC | 1521019 | MIMEDX GROUP INC | COM | 602496101 | 866 | 182757 | SH | DFND | 3 | 182757 | 0 | 0 | May 17th, 2022 01:38AM | May 17th, 2022 01:38AM | MiMedx | Pharmaceuticals & Biotechnology | ||
| nasdaq:mdxg | nasdaq:mdxg Shareholders | 13F-HR | 0000950123-22-006331 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Nuveen Asset Management, LLC | 1521019 | MIMEDX GROUP INC | COM | 602496101 | 3168 | 668329 | SH | DFND | 4 | 668329 | 0 | 0 | May 17th, 2022 01:38AM | May 17th, 2022 01:38AM | MiMedx | Pharmaceuticals & Biotechnology | ||
| nasdaq:mdxg | nasdaq:mdxg Shareholders | 13F-HR | 0000950123-22-006197 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | PARAMETRIC PORTFOLIO ASSOCIATES LLC | 932859 | MIMEDX GROUP INC COM | Common Stock | 602496101 | 79 | 16801 | SH | SOLE | 16801 | 0 | 0 | May 17th, 2022 01:37AM | May 17th, 2022 01:37AM | MiMedx | Pharmaceuticals & Biotechnology | |||
| nasdaq:mdxg | nasdaq:mdxg Shareholders | 13F-HR | 0000950123-22-005967 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | UBS Group AG | 1610520 | MIMEDX GROUP INC | COM | 602496101 | 1000 | 212401 | SH | DFND | 30 | 0 | 212401 | 0 | May 17th, 2022 01:35AM | May 17th, 2022 01:35AM | MiMedx | Pharmaceuticals & Biotechnology | ||
| nasdaq:mdxg | nasdaq:mdxg Shareholders | 13F-HR | 0000950123-22-005967 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | UBS Group AG | 1610520 | MIMEDX GROUP INC | COM | 602496101 | 87 | 18390 | SH | DFND | 1 | 0 | 0 | 18390 | May 17th, 2022 01:35AM | May 17th, 2022 01:35AM | MiMedx | Pharmaceuticals & Biotechnology | ||
| nasdaq:mdxg | nasdaq:mdxg Shareholders | 13F-HR | 0000950123-22-005967 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | UBS Group AG | 1610520 | MIMEDX GROUP INC | COM | 602496101 | 20 | 4315 | SH | DFND | 40 | 0 | 4315 | 0 | May 17th, 2022 01:35AM | May 17th, 2022 01:35AM | MiMedx | Pharmaceuticals & Biotechnology | ||
| nasdaq:mdxg | nasdaq:mdxg Shareholders | 13F-HR | 0000940394-22-001003 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | EATON VANCE MANAGEMENT | 1076598 | MIMEDX GROUP INC | COMMON STOCK | 602496101 | 212 | 45000 | SH | SOLE | 45000 | 0 | 0 | May 17th, 2022 01:35AM | May 17th, 2022 01:35AM | MiMedx | Pharmaceuticals & Biotechnology | |||
| nasdaq:mdxg | nasdaq:mdxg Shareholders | 13F-HR | 0000927337-22-000010 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | WOLVERINE TRADING, LLC | 927337 | MIMEDX GROUP INC | COM | 602496101 | 67 | 14100 | SH | Put | DFND | 1 | 0 | 0 | 0 | May 17th, 2022 01:34AM | May 17th, 2022 01:34AM | MiMedx | Pharmaceuticals & Biotechnology | |
| nasdaq:mdxg | nasdaq:mdxg Shareholders | 13F-HR | 0000927337-22-000010 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | WOLVERINE TRADING, LLC | 927337 | MIMEDX GROUP INC | COM | 602496101 | 77 | 16116 | SH | DFND | 1 | 0 | 0 | 0 | May 17th, 2022 01:34AM | May 17th, 2022 01:34AM | MiMedx | Pharmaceuticals & Biotechnology | ||
| nasdaq:mdxg | nasdaq:mdxg Shareholders | 13F-HR | 0000919574-22-003439 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | TWO SIGMA INVESTMENTS, LP | 1179392 | MIMEDX GROUP INC | COM | 602496101 | 932 | 197939 | SH | SOLE | 197939 | 0 | 0 | May 17th, 2022 01:34AM | May 17th, 2022 01:34AM | MiMedx | Pharmaceuticals & Biotechnology |